Pathogenetic Role of Monocyte Chemoattractant
https://doi.org/10.31550/1727-2378-2023-22-7-53-57
Abstract
Aim. To systematize modern scientific research that studies the role of monocytic chemoattractant in the development and progression of various diseases.
Key points. At present, the interest of the scientific community in the issues of the pathogenetic role of the monocyte-macrophage link of the cytokine spectrum in the development of a number of pathological changes in the body has increased.
Conclusion. The monocyte chemoattractant is one of the key components of endothelial dysfunction and possibly can be presented as a biological marker of various diseases, which will greatly assist in early diagnosis and organization of the treatment process accordingly.
About the Authors
Z. M. Nurzhanova
Astrakhan State Medical University; Astrakhan Regional Social and Rehabilitation Center “Rus”
Russian Federation
Russian Federation
121, Bakinskaya str., Astrakhan, 414000
14, Konovalova str., Astrakhan, 414042
O. A. Bashkina
Astrakhan State Medical University
Russian Federation
Russian Federation
121, Bakinskaya str., Astrakhan, 414000
M. A. Samotrueva
Astrakhan State Medical University
Russian Federation
Russian Federation
121, Bakinskaya str., Astrakhan, 414000
A. A. Shilova
Astrakhan State Medical University
Russian Federation
Russian Federation
121, Bakinskaya str., Astrakhan, 414000
References
1. Ivanov A.N., Grechikhin A.A., Norkin I.A., Puchinyan D.M. Methods of endothelial dysfunction diagnosis. Regional blood circulation and microcirculation. 2014;13(4):4–11. (in Russian). DOI: 10.24884/1682-6655-2014-13-4-4-11
2. Vasina L.V., Petrishchev N.N., Vlasov T.D. Markers of endothelial dysfunction. Regional blood circulation and microcirculation. 2017;16(1):4–15. (in Russian). DOI: 10.24884/1682-6655-2017-16-1-4-15
3. Shadmanov A.K., Abdurakhimov A.H., Khegay L.N., Askarov O.O. The role of endothelial dysfunction in the pathogenesis of diseases. Re-health journal. 2021;2(10): 122–129. (in Russian).
4. Krausgruber T., Fortelny N., Fife-Gernedl V. et al. Structural cells are key regulators of organ-specific immune responses. Nature. 2020;583(7815):296–302. DOI: 10.1038/s41586-020-2424-4
5. Vlasova T.I., Petrishchev N.N., Vlasov T.D. Endothelial dysfunction as the typical pathological state. Regional blood circulation and microcirculation. 2022;21(2):4–15. (in Russian). DOI: 10.24884/1682-6655-2022-21-2-4-15
6. Mel’nikova Y.S., Makarova T.P. Endothelial dysfunction as the key link of chronic diseases pathogenesis. Kazan medical journal. 2015;96(4: 659-665. (in Russian). DOI: 10.17750/KMJ2015-659
7. Chiva-Blanch G., Sala-Vila A., Crespo J. et al. The Mediterranean diet decreases pro-thrombotic microvesicle release in asymptomatic individuals at high cardiovascular risk. Clin. Nutr. 2020;39(11): 3377–3384. DOI: 10.1016/j.clnu.2020.02.0
8. Michurova M.C., Kalashnikov V.Yu., Smirnova O.M. et al. Endothelial progenitor cells in diabetes complications. Diabetes mellitus. 2015;18(1):24–32. (in Russian).
9. Martynov M.Yu, Bogolepova A.N, Yasamanova A.N. Endothelial dysfunction in COVID-19 and cognitive impairment. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2021;121(6):93–99. (in Russian). DOI: 10.17116/jnevro202112106193
10. Afonasieva T.M. Endothelial dysfunction. Possibilities of early diagnosis. Health and education in the XXI century. 2016;18(11):101–104 (in Russian).
11. Gozhenko A.I., Kuznetsova H.S., Kuznetsova K.S. et al. Endothelial dysfunction in the pathogenesis of diabetes complications. The message I. Endothelial dysfunction: etiology, pathogenesis and diagnostic methods. Endokrynologiya. 2017;22(2):171–81.
12. Stepanova T.V., Ivanov A.N., Popykhova E.B., Lagutina D.D. Molecular markers of endothelial dysfunction. Modern problems of science and education. 2019;(1):37. (in Russian).
13. Kuznetsova I.V. Endothelial dysfunction as a link between menopausal syndrome and cardiovascular diseases. Effective pharmacotherapy. 2019;15(32):32–40. (in Russian). DOI: 10.33978/2307-3586-2019-15-32-32-40
14. Amelina I.P., Solov'eva E.Iu. Oxidative stress and inflammation as links in a chain in patients with chronic cerebrovascular diseases. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2019;119(4):106–114. (in Russian). DOI: 10.17116/jnevro2019119041106
15. Pizov A.V., Pizov N.A., Skachkova O.A., Pizovа N.V. Endothelial function in normal and pathological conditions. Medical Council. 2019;(6):154–159. (in Russian). DOI: 10.21518/2079-701X-2019-6-154-159
16. Fateeva V.V., Vorob'eva O.V. Cerebral markers of endothelial dysfunction in chronic brain ischemia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2017;117(4):107–111. (in Russian). DOI: 10.17116/jnevro201711741107-111
17. Sadikova R.I., Mutalova E.G. Effect of the cytokine network and role of intercellular adhesion molecules in endothelial dysfunction development in patients with acute myocardial infarction. Practical Medicine. 2018;16(9):92–96. (in Rus-sian).
18. Dommel S., Blüher M. Does C-C motif chemokine ligand 2 (CCL2) link obesity to a pro-inflammatory state? Int. J. Mol. Sci. 2021;22(3):1500. DOI: 10.3390/ijms22031500
19. Nurzhanova Z.M., Shilova A.A., Bashkina O.A., Samotrueva M.A. Estimation of the level of endothelial factor of vascular growth and monocytic chemoattractant in children cerebral palsy. Humans and their health. 2021;24(3):33–38. (in Russian). DOI: 10.21626/vestnik/2021-3/04
20. Nikitina V.V., Zaharova N.B. Value МСР-1 as predict vascular disturbances. Saratov Journal of Medical Scientific Research. 2010;6(4):786–790. (in Russian)
21. Afonin A.A., Lebedenko A.A., Panova I.V. et al. Role of monocytic chemoattractant protein-1 in violation of the blood-brain barrier and the formation of cerebral pathology. Modern problems of science and education. 2022;(6-2):8. (in Russian)
22. Matveeva L.V., Kapkaeva R.C., Chudajkin A.N., Mishanina L.S. Changes monocyte chemoattractants protein-1 in Helicobacter pylori-associated gastroduodenal diseases. Russian Journal of Infection and Immunity. 2018;8(2):150–156. (in Russian). DOI: 10.15789/2220-7619-2018-2-150-156
23. Kolotov K.A., Rasputin P.G. Monocytic chemotactic protein-1 in physiology and medicine (review of literature). Perm Medical Journal. 2018;35(3):99–105. (in Russian). DOI: 10.17816/pmj35399-105
24. Panee J. Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes. J. Panee. Cytokine. 2012;60:1–12. DOI: 10.1016/j.cyto.2012.06.018
25. Batiushin M.M., Gadaborsheva H.Z., Sarvilina I.V. et al. The relationship of MCP-1 and tubulointerstitial fibrosis in chronic glomerulonephritis. nephrology (Saint-Petersburg). 2017;21(5): 22–27. (in Russian). DOI: 10.24884/1561-6274-2017-21-5-19-24
26. Fabene P.F., Bramanti P., Constantin G. The emerging role for chemokines in epilepsy. J. Neuroimmunol. 2010. 27;224(1-2): 22–27. DOI: 10.1016/j.jneuroim.2010.05.016
27. Fateeva V.V., Vorob'eva O.V. Cerebral markers of endothelial dysfunction in chronic brain ischemia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2017;117(4):107–111. (in Russian). DOI: 10.17116/jnevro201711741107-111
28. Kwaifa I.K., Bahari H., Yong Y.K., Noor S.M. Endothelial dysfunction in obesity-induced inflammation: molecular mechanisms and clinical implications. Biomolecules. 2020;10(2):291. DOI: 10.3390/biom10020291
29. Moskalev A.V., Sboychakov V.B., Tsygan V.N., Apchel A.V. Chemokines’ role in immunopathogenesis of atherosclerosis. Bulletin of the Russian Military Medical Academy. 2018;20(1):195–202. (in Russian). DOI: 10.17816/brmma12310
30. Chumakova S.P., Urazova O.I., Shipulin V.M. et al. Differentiation and subpopulation composition of VEGFR2+ cells in the blood and bone marrow in ischemic cardiomyopathy. Bulletin of Siberian Medicine. 2022;21(3):120–131. (in Russian). DOI: 10.20538/1682-0363-2022-3-120-131
31. Bunin V.A., Linkova N.S., Palmseva E.M., Kozlov K.L. Levels of the MCP-1 cytokine in peripheral tissues as a marker of progression of coronary heart disease in the elderly. Complex problems of cardiovascular diseases. 2017;6(4):14–15. (in Russian).
32. Ragino Yu.I., Shcherbakova L.V., Oblaukhova V.I. et al. Blood adipokins in young people with early ischemic heart disease on the background of abdominal obesity. Kardiologiia. 2021;61(4):32–38. (in Russian). DOI: 10.18087/cardio.2021.4.n1369
33. Shishkin A.N., Kniazeva A.I. Endothelial dysfunction in patients with obesity. Regional blood circulation and microcirculation. 2022;21(3):4–11. (in Russian). DOI: 10.24884/1682-6655-2022-21-3-4-11
34. Marisa C., Lucci I., Di Giulio C. et al. MCP-1 and MIP-2 expression and production in BB diabetic rat: effect of chronic hypoxia. Mol. Cell. Biochem. 2005;276(1-2):105–111. DOI: 10.1007/s11010-005-3556-4
35. Matveeva L.V. Changes in monocytic chemoattractant protein-1 in gastric cancer. Advances in molecular oncology. 2017;4(4):137. (in Russian)
36. Li M., Knight D.A., Snyder A.L. et al. A role for CCL2 in both tumor progression and immunosurveillance. Oncoimmunology. 2013;2(7):e25474. DOI: 10.4161/onci.25474
37. Huie J.R., Diaz-Arrastia R., Yue J.K. et al. Testing a multivariate proteomic panel for traumatic brain injury biomarker discovery: A TRACK-TBI Pilot Study. J. Neurotrauma. 2019;36(1):100–110. DOI: 10.1089/neu.2017.5449
38. Vorob’eva O.V., Fateeva V.V. Association of markers of endothelial dysfunction with depression in middle-aged patients with cerebral microangiopathy. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2021;121(4):7–11. (in Russian). DOI: 10.17116/jnevro20211210417
39. Cerri C., Genovesi S., Allegra M. et al. The Chemokine CCL2 mediates the seizure-enhancing effects of systemic inflammation. J. Neurosci. 2016;36(13):3777–3788. DOI: 10.1523/JNEUROSCI.0451-15.2016
40. Wang C., Yang L., Zhang J. et al. Higher expression of monocyte chemoattractant protein 1 and its receptor in brain tissue of intractable epilepsy patients. J. Clin. Neurosci. 2016;28:134–140. DOI: 10.1016/j.jocn.2015.07.033
41. Di Battista A.P., Rhind S.G., Hutchison M.G. et al. Inflammatory cytokine and chemokine profiles are associated with patient outcome and the hyperadrenergic state following acute brain injury. J. Neuroinflammation. 2016;13:40. DOI: 10.1186/s12974-016-0500-3
42. Ragino Yu.I., Stryukova E.V., Murashov I.S. et al. Association of endothelial dysfunction factors with the presence of unstable atherosclerotic plaques in the coronary arteries. Russian Journal of Cardiology. 2019;(5):26–29. (in Russian). DOI: 10.15829/1560-4071-2019-5-26-29
Review
For citations:
Nurzhanova Z.M., Bashkina O.A., Samotrueva M.A., Shilova A.A. Pathogenetic Role of Monocyte Chemoattractant. Title. 2023;22(7):53-57. (In Russ.) https://doi.org/10.31550/1727-2378-2023-22-7-53-57
Views:
14
Email this article 